This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Paion Ag's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $2.223. Paion Ag's 10-Year median PS Ratio is 33.7427. Therefore, the Median PS Value for today is $75.01.
As of today (2024-05-17), Paion Ag's share price is $0.0251. Paion Ag's Median PS Value is $75.01. Therefore, Paion Ag's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Paion Ag's Median PS Value or its related term are showing as below:
During the past 13 years, the highest Price to Median PS Value of Paion Ag was 2.21. The lowest was 0.04. And the median was 0.56.
PAIOF's Price-to-Median-PS-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.85 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Paion Ag Median PS Value Historical Data
The historical data trend for Paion Ag's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Paion Ag's Median PS Value
For the Drug Manufacturers - Specialty & Generic subindustry, Paion Ag's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paion Ag's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Paion Ag's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Paion Ag's Price-to-Median-PS-Value falls into.
Paion Ag Median PS Value Calculation
Paion Ag's Median PS Value for today is calculated as
10-Year Median PS Ratio is 33.7427.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paion Ag's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $2.223.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paion Ag (OTCPK:PAIOF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Paion Ag's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.0251
/
75.01
=
0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paion Ag Median PS Value Related Terms
Thank you for viewing the detailed overview of Paion Ag's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PAIOF has been successfully added to your 